Febuxostat Tablet
Product Images NDC 0054-0413

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 0054-0413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Febuxostat Chemical Structure (Fcf23fa1 Bc2d 4cdf Bf25 51a9ee09fa0d 01)

FDA Label Image

Febuxostat-bottle-label-80-mg.jpg (Image 01)

Febuxostat-bottle-label-80-mg.jpg (Image 01)
This is a description of a medication called Febuxostat, which is available in 40mg tablets. The text provides usage instructions and storage requirements, including a warning not to accept the medication if the bottle opening is broken or missing. A National Drug Code (NDC) is also provided. The medication is manufactured by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Image 02

Image 02
Each tablet contains 80 mg of febuxostat. Usual dosage and storage instructions are detailed in the package insert. The tablets should be stored at a temperature range of 20° to 26°C and protected from light. The NDC number is 0054-0414-13, and the medication is distributed by Hikma Pharmaceuticals USA Inc. If the bottle seal is broken or missing, do not accept. Pharmacist dispensing guidelines should be followed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.